Kotak 
Dealstreet

Kotak PE invests 400 crore in Biorad Medisys: Luthra advises

Kotak Strategic Situations India Fund II invested ₹400 crore.

Bar & Bench

Kotak Strategic Situations India Fund II, managed by Kotak Alternate Asset Managers Limited, has made an investment of up to ₹400 Crore in medical device manufacturer Biorad Medisys Private Limited.

Luthra and Luthra Law Offices India represented Kotak in this investment deal.

The transaction team consisted of Nishant Singh (Partner), Prachi Pandit (Managing Associate), Saksham Madan (Managing Associate), Manushi Shah (Associate), Varshini Ramesh (Associate), Aditi Nagpal (Associate), Charith Reddy (Associate), Kashish Singhal (Associate), Maitri Meghani (Associate) and Aashi Shah (Associate).

Nishant Singh

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.

VERTICES PARTNERS, IndusLaw, Transaction Square act on Luma Fertility fundraise

BCCI turns down offer by Champak magazine to settle trademark case over IPL robotic dog

Forced pregnancy tests, CCTV surveillance: Bombay High Court takes suo motu note of abuse at children's home

Trilegal, TT&A, Hogan Lovells act on Emmvee ₹3,000 crore proposed IPO

Areete Law Offices, Chir Amrit Legal advise on Chhattisgarh School JV

SCROLL FOR NEXT